1
|
Korbi AE, Tkhayat SB, Bouatay R, Ferjaoui M, Kolsi N, Harrathi K, Koubaa J. [Therapeutic outcomes of nasopharyngeal carcinomas: a single-center study conducted at the Fattouma Bourguiba University Hospital in Monastir, Tunisia]. Pan Afr Med J 2021; 38:143. [PMID: 33912313 PMCID: PMC8052626 DOI: 10.11604/pamj.2021.38.143.15510] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2018] [Accepted: 01/19/2021] [Indexed: 11/24/2022] Open
Abstract
Introduction les carcinomes nasopharyngés (CNP) sont relativement fréquents dans le pourtour méditerranéen. La survie a été largement améliorée avec les nouvelles techniques d´irradiation et les nouvelles molécules de chimiothérapie. L´objectif de notre étude est d´analyser les résultats thérapeutiques et décrire les facteurs pronostiques des CNP. Méthodes il s´agit d´une étude rétrospective menée entre janvier 1995 et décembre 2014, des observations de patients traités et suivis dans notre service pour un carcinome du nasopharynx. Le recueil des données a été réalisé à partir d´une fiche type. L´analyse statistique a été réalisée à l´aide du logiciel SPSS. La survie a été calculée selon la méthode de Kaplan-Meier. Résultats soixante-treize cas de CNP ont été colligés. L´âge moyen était de 48 ans. Une prédominance masculine a été notée. La majorité des tumeurs (56%) étaient localement avancées (T3-T4). Après un recul moyen de 45,5 mois, le taux de récidives locorégionales était de 19,4%. Trois patients (4%) ont présenté des métastases osseuses. La survie globale à 5 ans était de 65%. Les facteurs influençant positivement la survie globale à l´analyse étaient le stade TNM précoce et le fractionnement de 1,8 Grays/séance de la radiothérapie. Les taux de récidives locales et ganglionnaires étaient respectivement de 13,8% et 5,5%, essentiellement pour des tumeurs classées T4 N2. Les séquelles thérapeutiques étaient dominées par les otites séromuqueuses (42,7%), le trismus (38,7%) et la xérostomie (32%). Conclusion la survie globale des CNP s´est améliorée particulièrement avec l´avènement de la radio-chimiothérapie concomitante. Néanmoins, la toxicité tardive invalidante demeure non négligeable. Les facteurs de bon pronostic retrouvés dans cette étude étaient le stade tumoral précoce ainsi que la modalité de fractionnement de la radiothérapie.
Collapse
Affiliation(s)
- Amel El Korbi
- Service d´Otorhinolaryngologie et de Chirurgie Cervico-Faciale, Centre Hospitalier Universitaire Fattouma Bourguiba, Monastir, Tunisie.,Unité de Recherche, Qualité et Sécurité des Soins (UR12SP41), Université de Monastir, Monastir, Tunisie
| | - Sarra Ben Tkhayat
- Service d´Otorhinolaryngologie et de Chirurgie Cervico-Faciale, Centre Hospitalier Universitaire Fattouma Bourguiba, Monastir, Tunisie
| | - Rachida Bouatay
- Service d´Otorhinolaryngologie et de Chirurgie Cervico-Faciale, Centre Hospitalier Universitaire Fattouma Bourguiba, Monastir, Tunisie
| | - Mehdi Ferjaoui
- Service d´Otorhinolaryngologie et de Chirurgie Cervico-Faciale, Centre Hospitalier Universitaire Fattouma Bourguiba, Monastir, Tunisie
| | - Naourez Kolsi
- Service d´Otorhinolaryngologie et de Chirurgie Cervico-Faciale, Centre Hospitalier Universitaire Fattouma Bourguiba, Monastir, Tunisie
| | - Khaled Harrathi
- Service d´Otorhinolaryngologie et de Chirurgie Cervico-Faciale, Centre Hospitalier Universitaire Fattouma Bourguiba, Monastir, Tunisie
| | - Jamel Koubaa
- Service d´Otorhinolaryngologie et de Chirurgie Cervico-Faciale, Centre Hospitalier Universitaire Fattouma Bourguiba, Monastir, Tunisie
| |
Collapse
|
2
|
Bohli M, Tebra S, Bouaouina N. Nasopharyngeal carcinoma with cutaneous metastases. Eur Ann Otorhinolaryngol Head Neck Dis 2019; 136:409-411. [PMID: 31000368 DOI: 10.1016/j.anorl.2019.04.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
INTRODUCTION Cutaneous metastases from nasopharyngeal carcinoma are extremely rare and associated with a poor prognosis. CASE REPORTS We retrospectively reviewed 820 patients with nasopharyngeal carcinoma treated over a 20-year period in the radiotherapy department of Farhat Hached hospital in Sousse and Ibn Khaldoun Medical centre, Hammam Sousse. Two of these patients presented cutaneous metastases. The skin lesions appeared during radiotherapy and 3 months after treatment of the primary tumour. Cutaneous metastases present as multiple painless nodules and erythematous plaques. Cutaneous metastases were associated with other metastatic sites (liver, bone). One patient received chemotherapy. Both patients died in a context of rapidly progressive disease. DISCUSSION Nasopharyngeal carcinoma with cutaneous metastases is a rapidly fatal disease. In the light of these two cases and a review of the literature, patients with this disease are aged between 30 and 63 years with a marked male predominance. Cutaneous metastases are correlated with a more advanced primary tumour. The main sites are the trunk and scalp. There is no standard treatment modality for this disease and survival does not exceed 9 months.
Collapse
Affiliation(s)
- M Bohli
- Department of radiotherapy, Farhat Hached hospital, Sousse, Tunisia.
| | - S Tebra
- Department of radiotherapy, Farhat Hached hospital, Sousse, Tunisia
| | - N Bouaouina
- Department of radiotherapy, Farhat Hached hospital, Sousse, Tunisia
| |
Collapse
|
3
|
Bouaouina N, Ouni S, Kanoun SB, Neffeti AB, Kermani W, Abdelkefi M. [Metastatic nasopharynx cancer at diagnosis: clinical and prognostic (study of 51 cases)]. Pan Afr Med J 2018; 29:155. [PMID: 30050619 PMCID: PMC6057577 DOI: 10.11604/pamj.2018.29.155.11257] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2016] [Accepted: 08/09/2017] [Indexed: 11/18/2022] Open
Abstract
L’objectif de cette étude rétrospective était de détailler les différents aspects épidémiologiques, cliniques, thérapeutiques et pronostiques du cancer du cavum d'emblée métastatique dans le centre Tunisien. Il s’agit d’une étude portant sur 51 patients atteints d’un cancer du nasopharynx (CNP) histologiquement prouvé et métastatique d’emblée, soit au moment du diagnostic , colligés dans les services ORL du CHU Farhat Hached de Sousse et les services de radiothérapie du centre tunisien, à savoir du CHU Farhat Hached de Sousse, et du centre médical Ibn Khaldoun de Hammam Sousse, entre Janvier 1995 et Décembre 2010. Cinquante et un patients atteints de cancer du nasopharnx, d’emblée métastatiques ont été recensés. L’âge moyen était de 49 ans. Le Sex-Ratio était de 6,2. Les métastases osseuses étaient les plus fréquentes (94,1%), suivies par les métastases hépatiques (34,6%). Sur le plan thérapeutique, la majorité de nos patients a reçu une chimiothérapie (41 patients), dont 31 en association avec une radiothérapie. Le protocole adriamycine et cisplatine a été le plus fréquemment utilisé (92,6%). Vingt patients ont eu une radiothérapie cervicofaciale à intention curative (doses ≤ 70 Gy), quatorze autres patients ont reçu au niveau du cavum une radiothérapie à visée symptomatique ( doses de 30Gy en 10 séances) associée à une irradiation des sites métastatiques dans 9 cas. Les survies globales à 2 ans et à 5 ans étaient respectivement de 29% et de 10%. Au stade de métastases inaugurales, le cancer du cavum est une maladie grave, rapidement mortelle malgré les avancées thérapeutiques. Au vue des données de notre étude et de celles de la littérature, la chimiothérapie à base de cisplatine et la radiothérapie cervico-faciale à doses curatives et celle des métastases a permis d’obtenir de longues survies et même des réponses complètes. Les futurs essais pourraient tester de nouvelles molécules en vue d'une intensification thérapeutique.
Collapse
Affiliation(s)
| | - Sarra Ouni
- Service de Carcinologie Radiothérapie, CHU Farhat Hached, Sousse, Tunisie
| | | | - Abir Ben Neffeti
- Service de Carcinologie Radiothérapie, CHU Farhat Hached, Sousse, Tunisie
| | - Wassim Kermani
- Service d'Oto-Rhino-Laryngoglogie, CHU Farhat Hached, Sousse, Tunisie
| | - Mohamed Abdelkefi
- Service d'Oto-Rhino-Laryngoglogie, CHU Farhat Hached, Sousse, Tunisie
| |
Collapse
|
4
|
M'hamdi H, Baizig NM, ELHadj OE, M'hamdi N, Attia Z, Gritli S, Gamoudi A, El May MV, A El May. Usefulness of IGF-1 serum levels as diagnostic marker of nasopharyngeal carcinoma. Immunobiology 2016; 221:1304-8. [PMID: 27312888 DOI: 10.1016/j.imbio.2016.05.008] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2016] [Revised: 05/12/2016] [Accepted: 05/23/2016] [Indexed: 12/12/2022]
Abstract
BACKGROUND The role of IGF-1 in promoting cancer has been investigated for many years. The aim of this study is to explore the relationship between rates of IGF-1 and NPC and to evaluate association of IGF-1 with clinical parameters. MATERIALS AND METHODS IGF-1 levels was measured by Elisa test among 82 NPC patients and 60 healthy controls RESULTS Our results showed, for the first time, a significant increased levels of IGF-I in NPC by in comparison with healthy controls (p<0.01). According to the age, sex and tumor size of NPC patients, we demonstrated that IGF-1 concentrations are significantly higher in NPC aged over 30 years compared to patients aged less than 30 years (p<0.01). The IGF-1 levels are, also, higher among women compared to men (p<0.01). The concentrations of IGF-1 were positively correlated with tumor size of NPC patients (p<0.01). CONCLUSION IGF-I could be a good nasopharyngeal cancer diagnostic marker.
Collapse
Affiliation(s)
- H M'hamdi
- Laboratory of Immuno-Histo-Cytology, Institute of Carcinology; Salah Azaiz, Tunis, Tunisia.
| | - N Mokni Baizig
- Laboratory of Immuno-Histo-Cytology, Institute of Carcinology; Salah Azaiz, Tunis, Tunisia.
| | - O ElAmine ELHadj
- Laboratory of Immuno-Histo-Cytology, Institute of Carcinology; Salah Azaiz, Tunis, Tunisia.
| | - N M'hamdi
- Department of Animal Sciences National Institute of Agronomy of Tunis, Tunisia.
| | - Z Attia
- Department of ORL. Institute of Carcinology Salah Azaiz of Tunis, Tunisia.
| | - S Gritli
- Department of ORL. Institute of Carcinology Salah Azaiz of Tunis, Tunisia.
| | - A Gamoudi
- Laboratory of Immuno-Histo-Cytology, Institute of Carcinology; Salah Azaiz, Tunis, Tunisia.
| | - M Veronique El May
- Research Unit 01/UR/08-07.Faculty of Medicine, Tunis, University of Tunis El Manar,Tunisia.
| | - A El May
- Laboratory of Immuno-Histo-Cytology, Institute of Carcinology; Salah Azaiz, Tunis, Tunisia.
| |
Collapse
|
5
|
Douik H, Romdhane NA, Guemira F. Are HLA-E*0103 alleles predictive markers for nasopharyngeal cancer risk? Pathol Res Pract 2016; 212:345-9. [PMID: 26896927 DOI: 10.1016/j.prp.2016.01.010] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/19/2015] [Accepted: 01/26/2016] [Indexed: 10/22/2022]
Abstract
BACKGROUND Nasopharyngeal carcinoma (NPC) is a particular entity of head neck cancer, tightly related to Epstein-Barr virus infection and thus to HLA genes. In this study, we aimed to analyze HLA-E polymorphism in NPC advent and prognosis. 130 unrelated patients with CNP and 180 unrelated and healthy controls were included in our study. HLA-E genotyping was performed by PCR/RFLP method; SPSS (13.0) was used for statistical analysis, and survival curbs were established with the "Kaplan-Meier" method (Log Rank<0.05). RESULTS We found a significant difference within HLA-E*103 variants between patients and controls: E*1031 and E*1032 were associated with CNP (OR=1.613, p=0.013 and OR=1.0809, p=0.055), and E*1033 with controls (OR=0.254, p<10(-4)). CONCLUSION Our study reveals that HLA-E polymorphism is associated with nasopharyngeal cancer. HLA-E expression studies could be used to understand the implication of E*103 variants.
Collapse
Affiliation(s)
- Hayet Douik
- Clinical Biology Department, Salah Azaiz Institute of Cancer, 1006 Bab Saadoun, Tunis, Tunisia.
| | - Neila Attia Romdhane
- Statistic and Epidemiology Department, Faculty of Medicine, 1007, Djebel Lakhdar, La Rabta, Tunis, Tunisia
| | - Fethi Guemira
- Clinical Biology Department, Salah Azaiz Institute of Cancer, 1006 Bab Saadoun, Tunis, Tunisia
| |
Collapse
|
6
|
Ben Chaaben A, Abaza H, Douik H, Chaouch L, Ayari F, Ouni N, Mamoghli T, Ben Guezella D, Mejri R, Harzallah L, Guemira F. [Genetic polymorphism of cytochrome P450 2E1 and the risk of nasopharyngeal carcinoma]. Bull Cancer 2015; 102:967-72. [PMID: 26582733 DOI: 10.1016/j.bulcan.2015.09.013] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2015] [Accepted: 09/17/2015] [Indexed: 01/15/2023]
Abstract
Cytochrome P450 2E1 (CYP2E1) is a detoxifying enzyme that belongs to the phase I metabolism of xenobiotics. This enzyme is encoded by a highly polymorphic gene whose common polymorphism corresponds to the substitution of cytosine (C) and thymine (T) at position -1019 (rs2031920). This polymorphism has been identified in several cancers including nasopharyngeal cancer (NPC). The study involved 124 patients with nasopharyngeal carcinoma, compared with 166 healthy controls. The presence or absence of the polymorphism is determined by PCR-RFLP. The frequency comparison between the two groups is determined by the χ(2) test. The analysis of our results showed a significant difference between the two groups regarding the mutant genotype (C2/C2) (5% vs. 0.5%, P=0.04) and has a risk factor for NPC in Tunisia (OR=8.39; CI 95% [0.99-388.1]). Also, the C2 allele was significantly associated with the group of patients than the control group (6% vs. 2%, P=0.016) and increased three times the risk of NPC in Tunisia (OR=2.99, CI 95% [1.12-8.79]). Our results confirm the results reported in other populations and emphasize the importance of the involvement of this gene in the development of detoxification of the NPC, which seems more and more strongly associated with environmental factors.
Collapse
Affiliation(s)
- Arij Ben Chaaben
- Institut Salah Azaiz, laboratoire de biologie Clinique, Tunis, Tunisie.
| | - Hajer Abaza
- Institut Salah Azaiz, laboratoire de biologie Clinique, Tunis, Tunisie
| | - Hayet Douik
- Institut Salah Azaiz, laboratoire de biologie Clinique, Tunis, Tunisie
| | - Leila Chaouch
- Institut Pasteur de Tunis, laboratoire d'hématologie moléculaire et cellulaire, Tunis, Tunisie
| | - Fayza Ayari
- Institut Salah Azaiz, laboratoire de biologie Clinique, Tunis, Tunisie
| | - Nesrine Ouni
- Institut Salah Azaiz, laboratoire de biologie Clinique, Tunis, Tunisie
| | - Tasnim Mamoghli
- Institut Salah Azaiz, laboratoire de biologie Clinique, Tunis, Tunisie
| | | | - Rachida Mejri
- Institut Salah Azaiz, laboratoire de biologie Clinique, Tunis, Tunisie
| | - Latifa Harzallah
- Institut Salah Azaiz, laboratoire de biologie Clinique, Tunis, Tunisie
| | - Fethi Guemira
- Institut Salah Azaiz, laboratoire de biologie Clinique, Tunis, Tunisie
| |
Collapse
|
7
|
Allaya N, Khabir A, Sallemi-Boudawara T, Sellami N, Daoud J, Ghorbel A, Frikha M, Gargouri A, Mokdad-Gargouri R, Ayadi W. Over-expression of miR-10b in NPC patients: correlation with LMP1 and Twist1. Tumour Biol 2015; 36:3807-14. [DOI: 10.1007/s13277-014-3022-6] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2014] [Accepted: 12/26/2014] [Indexed: 12/20/2022] Open
|
8
|
Bahriz M, Kassa R, Tibouk A, Amir Z, Terkmani F, Chilla D, Asselah F, Benhalima M, Djennaoui D, El Hadjene M, Melouli H, Oukrif S, Bouzid K. Cancer du nasopharynx en Algérie. Ann Pathol 2010; 30:126-9. [DOI: 10.1016/j.annpat.2010.07.042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2010] [Accepted: 07/29/2010] [Indexed: 11/29/2022]
|
9
|
Abstract
Nasopharyngeal carcinomas (NPC) are predominantly of undifferentiated type (UCNT or undifferentiated carcinoma of nasopharyngeal type), rare (<1/100,000) and sporadic in occidental countries, but endemic in the Mediterranean area of intermediate incidence (2 to 10/100,000) and highly frequent (>10/100,000) in South East Asia. NPC staging is based on TNM UICC 2002 that has a prognostic and therapeutic orientation impact. Irradiation of the primitive tumor and its extensions remains the standard loco-regional treatment. The recent introduction of primary and concomitant chemotherapy leads to an improvement in terms of overall and disease-free survival, specially for for high-risk-patients (T3-4 and N2-3 disease). Prognosis remain linked to T, N, histologic type and quality of response to chemotherapy and radiotherapy.
Collapse
|
10
|
Eduardo B, Raquel C, Rui M. Nasopharyngeal carcinoma in a south European population: epidemiological data and clinical aspects in Portugal. Eur Arch Otorhinolaryngol 2010; 267:1607-12. [PMID: 20454799 DOI: 10.1007/s00405-010-1258-3] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2009] [Accepted: 04/15/2010] [Indexed: 11/26/2022]
Abstract
The incidence of nasopharyngeal carcinoma (NPC) varies worldwide, with higher rates in southern Asia, intermediate rates in Mediterranean basin countries as well as in Greenland and Alaska populations, and low rates in most of the western countries. The percentage of NPC types seems to vary according to the WHO classification. Portugal is also a Mediterranean basin country. The NPC patterns in Portuguese population is comparatively analyzed with a review of the related literature, concerning the overall incidence, male/female ratio, age of incidence, WHO type frequency, Epstein-Barr virus relationship and genetic susceptibility. The particular findings in the Portuguese population can be discussed in the light of genetic background and close relationships with potential exogenous oncogenic factors.
Collapse
Affiliation(s)
- Breda Eduardo
- Otorhinolaryngology Department, Portuguese Institute of Oncology, R. Dr. Ant. Bernardino Almeida, Porto, 4200-072, Portugal.
| | | | | |
Collapse
|
11
|
HLA association with nasopharyngeal carcinoma in southern Tunisia. Mol Biol Rep 2009; 37:2533-9. [PMID: 19714482 DOI: 10.1007/s11033-009-9769-y] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2009] [Accepted: 08/14/2009] [Indexed: 10/20/2022]
Abstract
In order to study the association of HLA-A, -B and/or DRB1, DQB1 and the nasopharyngeal carcinoma (NPC), 141 patients affected with NPC were typed for the HLA class I by serology method of microlymphocytotoxicity. Among these patients 101 were genotyped for HLA class II system by the PCR-SSP technique. HLA typing results were compared to those of 116 controls. We found that the HLA-A31 and -A33 antigens were significantly more expressed in patients than in the controls (P = 0.016 and 0.010, respectively) and the HLA-A19 antigen, was significantly more frequent in patients when compared to the controls (P = 0.007). The HLA-DRB1*03 and DRB1*13 alleles were significantly more frequent in patients as compared to the controls. The DRB1*01 allele was expressed with a frequency of 20.69% in the controls whereas it was only detected in 3.96% of the NPC patients. Furthermore, the DQB1*05 allele was expressed at a frequency which was significantly less important in affected patient (P = 0.03), whereas, the DQB1*02 allele was more frequent in patients (P = 0.643 x 10(-4)). Thus our study revealed a significant increase of HLA-A31, A33, A19, B16, B53 and DRB1*03, DRB1*13 and DQB1*02 alleles in our patients. These markers could play a predisposing role in the development of NPC. In contrast, a decrease of HLA-B14, -B35 and DRB1*01 and DQB1*05 alleles was found suggesting a likely protective effect.
Collapse
|
12
|
Tong YQ, Zhang ZJ, Liu B, Huang J, Liu H, Liu Y, Guo FJ, Zhou GH, Xie PL, Li YH, Zuo CH, Hu JY, Li GC. Autoantibodies as potential biomarkers for nasopharyngeal carcinoma. Proteomics 2008; 8:3185-93. [PMID: 18654982 DOI: 10.1002/pmic.200700651] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Autoantibody signatures, as new biomarkers, may improve the early detection of nasopharyngeal carcinoma (NPC). We constructed a T7 phage cDNA library from mixed NPC tissues, and we isolated 31 tumor-associated proteins using biopan enrichment techniques with sera from NPC patients and from healthy population. DNA sequence analysis showed that among 31 phage-displayed proteins, 22 have sequence identity with known or putative tumor-associated proteins. The results of immunochemical reactivity of patients' sera with phage-expressed proteins showed enrichment in the number of immunogenic phage clones in the biopanning process and also confirmed that antibodies were present in the sera of patients but not in the sera of healthy donors. The autoantibody against phage-expressed protein MAGE, HSP70, Fibronectin, and CD44 measured by ELISA had greater predictive value than that against EBNA-1, respectively. The antibody levels against MAGE in sera positively correlated with the clinical stages of NPC, and the antibody levels against other three proteins partly correlated with the clinical stages of NPC. Our studies suggested that the autoantibodies against tumor-associated antigens in the sera of NPC patients could be used as a screening test for NPC. Studies of the corresponding proteins may have significances in tumor biology, novel drug development, and immunotherapy.
Collapse
Affiliation(s)
- Yong-Qing Tong
- Cancer Research Institute, Xiang-Ya School of Medicine, Central South University, Hunan, PR China
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Trimeche M, Braham H, Ziadi S, Amara K, Hachana M, Korbi S. Investigation of allelic imbalances on chromosome 3p in nasopharyngeal carcinoma in Tunisia: high frequency of microsatellite instability in patients with early-onset of the disease. Oral Oncol 2008; 44:775-83. [PMID: 18206419 DOI: 10.1016/j.oraloncology.2007.10.001] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2007] [Revised: 10/05/2007] [Accepted: 10/05/2007] [Indexed: 11/24/2022]
Abstract
Tunisia is one of the world's intermediate risk areas for nasopharyngeal carcinoma (NPC). Loss of heterozygosity (LOH) on the short arm of chromosome 3 (3p) is the most frequent genetic change reported in NPC from endemic areas. In the present study, we investigate the incidence of LOH and microsatellite instability (MSI) on chromosome 3p in 49 microdissected primary NPC specimens and corresponding non-cancerous tissues from Tunisian patients using six microsatellite polymorphic markers. LOH at one or more markers was observed in 40 out of 48 informative cases (83.3%). The markers D3S1038 at 3p25.2-26.1 and D3S1076 at 3p21.1-21.2 have showed the highest frequency of LOH (51.3%), followed by D3S1067 at 3p14.3-21.1 (48.7%), D3S1568 at 3p21.3 (47.4%), D3S659 at 3p13 (15.3%), and D3S1228 at 3p14.1-14.2 (11%). Interestingly, MSI at one or more microsatellite markers was observed in 15 cases (31.2%). The highest frequency of MSI was presented by D3S1568 (18.4%), D3S1067 (17.9%), and D3S1038 (12.8%). With regard to clinicopathological features, LOH was found to be less common in young patients (under 25 years) than in adults (p=0.04), whereas MSI was found to be more frequent in patients under 45 years than in older patients (p=0.006). No significant correlation was found between LOH or MSI and the other clinicopathological features investigated including, gender, tumor size, lymph node metastasis, UICC clinical stage, and histological subtype. This study revealed different patterns of allelic imbalance on chromosome 3P in NPC between age groups in Tunisia, and suggests an alteration in the DNA mismatch repair machinery that may be, in part, responsible of the early age onset form of this disease in North African populations. More attention should be given to the mismatch repair system in the juvenile form of this disease in future studies.
Collapse
Affiliation(s)
- Mounir Trimeche
- Department of Pathology, University Hospital Farhat-Hached, Sousse, Tunisia.
| | | | | | | | | | | |
Collapse
|
14
|
Ayadi W, Feki L, Khabir A, Boudawara T, Ghorbel A, Charfeddine I, Daoud J, Frikha M, Hammami A, Karray-Hakim H. Polymorphism analysis of Epstein-Barr virus isolates of nasopharyngeal carcinoma biopsies from Tunisian patients. Virus Genes 2007; 34:137-45. [PMID: 17216568 DOI: 10.1007/s11262-006-0051-2] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2006] [Accepted: 10/11/2006] [Indexed: 12/26/2022]
Abstract
Many studies suggest that the focal distribution of nasopharyngeal carcinoma (NPC) may be influenced not only by host genetics, diet and environments but also by interplay with Epstein-Barr virus (EBV) genetics. Specific EBV gene variants (the A and C types, the BamHI f configuration, a C terminal 30 bp deletion and a N terminal loss of an XhoI site in the BNLF1 gene) have been explored in high incidence areas in southern Asian NPC patients. In contrast, in Tunisia where NPC represents the most frequent type of Head and Neck cancer the distribution of these polymorphisms remains poorly investigated. In order to characterize the epidemiology of EBV variants in Tunisian NPC patients, we have investigated the A or B type of the EBV nuclear antigen (EBNA)2 gene, the C or D type of the BamHI W1/I1 region, the F/f variants of the BamHI F region and the presence or the absence of the XhoI site, 30 bp deletion and Taq1 site in the BNLF1 gene in 47 NPC biopsies, 12 being younger than 30 and 35 older than 30. Our results show a unique genetic profile of the tumor EBV strains regarding the A and D types, the prototype F and retention of the XhoI restriction site in the N terminal region of BNLF1 gene. With regard to the C terminal region of this gene, four genetic profiles were detected: (1) the occurrence of the 30 bp deletion in association with the Taq1 site in 39 cases (83%), (2) the presence of the Taq1 site by itself in 5 cases, (3) the occurrence of the 30 bp deletion by itself in 2 cases and (4) the occurrence of a new deletion of 81 bp covering the 30 bp deletion in association with the Taq1 site in one case. With the exception of the 81 bp deletion, which has not been previously described in the literature, the summarized results have shown the same genetic profile in Tunisian NPC tumor isolates as tumor isolates from other North African and Mediterranean countries. Hence, the observed EBV polymorphisms are not fully specific of to the Tunisian NPCs. Nevertheless, the notion of a divergence between North African and Asian tumor EBV isolates is reinforced by this study.
Collapse
Affiliation(s)
- Wajdi Ayadi
- Laboratoire de Microbiologie, Faculté de Médecine, Hôpital Habib Bourguiba, Avenue Majida Boulila, 3029, Sfax, Tunisia
| | | | | | | | | | | | | | | | | | | |
Collapse
|